Over the years, the FDA has worked hard to avoid making Type II errors. A type I
ID: 3341092 • Letter: O
Question
Over the years, the FDA has worked hard to avoid making Type II errors. A type II error occurs when the FDA approves a drug that is not both safe and effective. For example, Omniflox, and antibiotic, had to be recalled less than six months after its approval due to reports of severe adverse reactions, which included a number of deaths. Similarly, Fenoterol, an inhaled drug intended to relieve asthma attacks, was found to increase the risk of death rather than decrease it. Is there a way the FDA can completely eliminate type II errors? if so how?
Explanation / Answer
Answer-
FDA must change its policies to determine whether drug is effective or not. It must increase the time of study to determine the effectiveness. Instead of instant approval of Omniflox and antibiotic, It must observe the effects over a 6-month or longer period to decide on how the drug goes to save lives of people or affect it. Similarly for Fenoterol, FDA must strict its methods and rules to test drug's effect which is expected to relieve asthma attacks rather than increase its rate.
This is how null hypothesis - Drug is effective and research hypothesis- Drug is ineffective- would be closely analysed and null hypothesis will be rejected if it is false or in other words eliminating Type 2 error.
TY!
Related Questions
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.